RJA
IX icon

Raymond James & Associates’s ORIX IX Stock Holding History

Raymond James & Associates’s Portfolio IX Stock Details IX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,465
Closed -$297K – 3963
2022
Q4 		$297K Buy
18,465
+1,180
+7% +$17.9K ﹤0.01% 3221
2022
Q3 		$244K Sell
17,285
-1,395
-7% -$22.8K ﹤0.01% 3310
2022
Q2 		$314K Sell
18,680
-19,180
-51% -$349K ﹤0.01% 3201
2022
Q1 		$756K Buy
37,860
+14,820
+64% +$303K ﹤0.01% 2789
2021
Q4 		$469K Buy
23,040
+535
+2% +$10.7K ﹤0.01% 3126
2021
Q3 		$425K Buy
22,505
+2,100
+10% +$38.6K ﹤0.01% 3188
2021
Q2 		$345K Sell
20,405
-655
-3% -$11.2K ﹤0.01% 3335
2021
Q1 		$357K Sell
21,060
-1,225
-5% -$20.9K ﹤0.01% 3244
2020
Q4 		$345K Sell
22,285
-2,385
-10% -$33.6K ﹤0.01% 3041
2020
Q3 		$309K Sell
24,670
-2,130
-8% -$26.2K ﹤0.01% 2941
2020
Q2 		$330K Sell
26,800
-1,440
-5% -$17.7K ﹤0.01% 2861
2020
Q1 		$334K Sell
28,240
-5,120
-15% -$80.8K ﹤0.01% 2697
2019
Q4 		$557K Buy
33,360
+3,695
+12% +$59.3K ﹤0.01% 2647
2019
Q3 		$446K Sell
29,665
-1,805
-6% -$27.1K ﹤0.01% 2729
2019
Q2 		$471K Sell
31,470
-1,910
-6% -$27.3K ﹤0.01% 2717
2019
Q1 		$480K Sell
33,380
-235,370
-88% -$3.47M ﹤0.01% 2673
2018
Q4 		$3.85M Sell
268,750
-17,500
-6% -$274K 0.01% 1229
2018
Q3 		$4.64M Buy
286,250
+30,835
+12% +$497K 0.01% 1262
2018
Q2 		$4.04M Sell
255,415
-125,000
-33% -$2.16M 0.01% 1326
2018
Q1 		$6.84M Buy
380,415
+129,475
+52% +$2.34M 0.01% 975
2017
Q4 		$4.25M Buy
250,940
+40,160
+19% +$680K 0.01% 1213
2017
Q3 		$3.41M Buy
210,780
+55,470
+36% +$892K 0.01% 1285
2017
Q2 		$2.42M Buy
155,310
+14,015
+10% +$219K 0.01% 1443
2017
Q1 		$2.1M Buy
141,295
+14,375
+11% +$223K ﹤0.01% 1495
2016
Q4 		$1.98M Buy
126,920
+6,260
+5% +$96.1K 0.01% 1491
2016
Q3 		$1.79M Buy
120,660
+6,725
+6% +$94.9K ﹤0.01% 1524
2016
Q2 		$1.46M Buy
113,935
+71,970
+172% +$1M ﹤0.01% 1512
2016
Q1 		$599K Buy
+41,965
New +$571K ﹤0.01% 1949

Other funds holding IX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Raymond James & Associates's IX Position: Q1 2023 in Review

Raymond James & Associates sold out of ORIX (IX) in Q1 2023, closing a stake of 18,465 shares — an estimated $297K sold.

Raymond James & Associates first reported a position in IX in Q1 2016 and held it in 28 quarters. The position peaked at $6.84M in Q1 2018. 121 funds tracked by Wall St. Rank hold IX as of Q1 2023.

  • Raymond James & Associates reported no remaining ORIX position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 18,465 ORIX shares in Q1 2023, an estimated $297K.
  • Raymond James & Associates first reported a position in ORIX in Q1 2016 and held it in 28 quarters.
  • Raymond James & Associates's ORIX position peaked at $6.84M in Q1 2018.
  • 121 funds tracked by Wall St. Rank held ORIX as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.